Gut Microbiome Modulation and Health Benefits of a Novel Fucoidan Extract from Saccharina latissima: A Double-Blind, Placebo-Controlled Trial
Microorganisms · 30.06.2025 · 13 (7) · 1545
DOI: 10.3390/microorganisms13071545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 30.06.2025. Verfasst von Gissel Garcia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San Lázaro No 701, Esq. a Belascoaín, Centro Habana, La Habana 10400,…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oceanium, LTD, Oceanium, Ltd..
Abstract (Originalsprache)
This randomized, double-blind, placebo-controlled, three-arm clinical trial evaluated the effects of a proprietary bioactive fucoidan-rich extract derived from Saccharina latissima (SLE-F) on gut microbial composition and function in healthy adults. The objective of the study was to assess the potential of SLE-F to beneficially modulate the gut microbiome, with this paper specifically reporting on microbial diversity, taxonomic shifts, and functional pathway outcomes. Ninety-one participants received either a low dose (125 mg), high dose (500 mg), or placebo twice daily for ninety days. The primary endpoint was the microbiome composition assessed via 16S rRNA sequencing (V3–V4 region), with secondary outcomes including surveys, adverse event monitoring, and clinical evaluations. High-dose supplementation resulted in dose-dependent improvements in the microbial diversity; increased abundance of beneficial taxa, including Bifidobacterium, Faecalibacterium, and Lachnospiraceae; and reductions in inflammation-associated taxa, such as Enterobacteriaceae and Pseudomonadota. A functional pathway analysis showed enhancement in short-chain fatty acid biosynthesis and carbohydrate metabolism. The low-dose group showed modest benefits, primarily increasing Bifidobacterium, with limited functional changes. In vitro colonic simulations further demonstrated a dose-dependent increase in short-chain fatty acids and postbiotic metabolite production following SLE-F exposure. SLE-F was well tolerated, with only mild, nonspecific adverse events reported. These findings support the potential of SLE-F as a safe and effective microbiome-modulating agent, warranting further study of the long-term use and synergy with dietary interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pathology Department, Hermanos Ameijeiras Clinical and Surgical Hospital, Calle San Lázaro No 701, Esq. a Belascoaín, Centro Habana, La Habana 10400, Cuba.
- Clinical Laboratory Department, Clinical Hospital "Hermanos Ameijeiras", Calle San Lázaro No 701, Esq. a Belascoaín, Centro Habana, La Habana 10400, Cuba.
- Institute of Cybernetics, Mathematics and Physics Havana University, La Habana 10400, Cuba.
- 7 Nutrition Department, Clinical Hospital "Hermanos Ameijeiras", Calle San Lázaro No 701, Esq. a Belascoaín, Centro Habana, La Habana 10400, Cuba.
- Protein Studies Center, Biology Faculty, Havana University, Calle 25 Entre Calle J e I No 455 Plaza, La Habana 10400, Cuba.
- Oceanium, Ltd., Malin House, Suite10 The European Marine Science Park, Dunbeg, Oban PA37 1SZ, UK.
ORCID-Profile: Gissel Garcia, Charles Bavington, Raúl de Jesús Cano
Förderung
- Oceanium, LTD
- Oceanium, Ltd.
Zitieren
APA
Garcia, G., Soto, J., Valenzuela, C., Bernal, M., Barreto, J., Luzardo, M. C., Kazlauskaite, R., Waslidge, N., Bavington, C., & Cano, R. J. (2025). Gut Microbiome Modulation and Health Benefits of a Novel Fucoidan Extract from Saccharina latissima: A Double-Blind, Placebo-Controlled Trial. Microorganisms, 13(7), 1545. https://doi.org/10.3390/microorganisms13071545
Vancouver
Garcia G, Soto J, Valenzuela C, Bernal M, Barreto J, Luzardo MC, et al. Gut Microbiome Modulation and Health Benefits of a Novel Fucoidan Extract from Saccharina latissima: A Double-Blind, Placebo-Controlled Trial. Microorganisms. 2025;13(7):1545. doi:10.3390/microorganisms13071545
BibTeX
@article{Garcia2025,
author = {Garcia, Gissel and Soto, Josanne and Valenzuela, Carmen and Bernal, Mirka and Barreto, Jesús and Luzardo, María de la C and Kazlauskaite, Raminta and Waslidge, Neil and Bavington, Charles and Cano, Raúl de Jesús},
title = {Gut Microbiome Modulation and Health Benefits of a Novel Fucoidan Extract from Saccharina latissima: A Double-Blind, Placebo-Controlled Trial},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {7},
pages = {1545},
doi = {10.3390/microorganisms13071545}
}
EUVIMED